Recursion Pharmaceuticals (RXRX) is back in focus after reporting fourth quarter and full year 2025 results, highlighting much higher quarterly revenue, a smaller net loss, and fresh commentary on its ...

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

Managers of electric grids say freezing temperatures and ice and snow could lead to power outages in many places, potentially leaving millions in the dark. By Ivan Penn and Rebecca F. Elliott As ...

Opinions expressed by Entrepreneur contributors are their own. Most entrepreneurs use AI like a spellchecker and then wonder why nothing changes. In 2026, leverage beats hustle. I’ll walk you through ...

Tommy Egan (Joseph Sikora) will go to extremes to get what he wants. The sixth episode of the third and final season of "Power Book IV: Force" will air on Starz on Friday, Dec. 12. Egan is steadfast ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Rock the Country festival: Artists dropping out amid Kid Rock controversy Lindsey Vonn breaks ...

The privacy-preserving decentralized AI platform is built on top of The Open Network, and users earn TON for renting out computing power. The Cocoon decentralized AI network, a privacy-preserving ...